A citation-based method for searching scientific literature

Ana Cristina Vargas, Leonard Da Silva, Sunil R Lakhani. Fam Cancer 2010
Times Cited: 10







List of co-cited articles
35 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.
Sunil R Lakhani, Marc J Van De Vijver, Jocelyne Jacquemier, Thomas J Anderson, Peter P Osin, Lesley McGuffog, Douglas F Easton. J Clin Oncol 2002
586
70

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.
Sunil R Lakhani, Jorge S Reis-Filho, Laura Fulford, Frederique Penault-Llorca, Marc van der Vijver, Suzanne Parry, Timothy Bishop, Javier Benitez, Carmen Rivas, Yves-Jean Bignon,[...]. Clin Cancer Res 2005
445
50

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays.
Anita L Bane, Jeanne C Beck, Ira Bleiweiss, Saundra S Buys, Edison Catalano, Mary B Daly, Graham Giles, Andy K Godwin, Hanina Hibshoosh, John L Hopper,[...]. Am J Surg Pathol 2007
95
50


Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.
Deann P Atchley, Constance T Albarracin, Adriana Lopez, Vicente Valero, Christopher I Amos, Ana Maria Gonzalez-Angulo, Gabriel N Hortobagyi, Banu K Arun. J Clin Oncol 2008
351
40

Incorporating tumour pathology information into breast cancer risk prediction algorithms.
Nasim Mavaddat, Timothy R Rebbeck, Sunil R Lakhani, Douglas F Easton, Antonis C Antoniou. Breast Cancer Res 2010
44
40

Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type.
William D Foulkes, Kelly Metcalfe, Ping Sun, Wedad M Hanna, Henry T Lynch, Parviz Ghadirian, Nadine Tung, Olufunmilayo I Olopade, Barbara L Weber, Jane McLennan,[...]. Clin Cancer Res 2004
220
40

Limited family structure and BRCA gene mutation status in single cases of breast cancer.
Jeffrey N Weitzel, Veronica I Lagos, Carey A Cullinane, Patricia J Gambol, Julie O Culver, Kathleen R Blazer, Melanie R Palomares, Katrina J Lowstuter, Deborah J MacDonald. JAMA 2007
130
30

Expanding the criteria for BRCA mutation testing in breast cancer survivors.
Janice S Kwon, Angelica M Gutierrez-Barrera, Diana Young, Charlotte C Sun, Molly S Daniels, Karen H Lu, Banu Arun. J Clin Oncol 2010
101
30

Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features.
Nadine Tung, Yihong Wang, Laura C Collins, Jennifer Kaplan, Hailun Li, Rebecca Gelman, Amy H Comander, Bridget Gallagher, Katharina Fetten, Karen Krag,[...]. Breast Cancer Res 2010
66
30

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.
S R Lakhani, J Jacquemier, J P Sloane, B A Gusterson, T J Anderson, M J van de Vijver, L M Farid, D Venter, A Antoniou, A Storfer-Isser,[...]. J Natl Cancer Inst 1998
507
30

Morphological predictors of BRCA1 germline mutations in young women with breast cancer.
M C Southey, S J Ramus, J G Dowty, L D Smith, A A Tesoriero, E E M Wong, G S Dite, M A Jenkins, G B Byrnes, I Winship,[...]. Br J Cancer 2011
31
30

Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers.
José Palacios, Emiliano Honrado, Ana Osorio, Alicia Cazorla, David Sarrió, Alicia Barroso, Sandra Rodríguez, Juan C Cigudosa, Orland Diez, Carmen Alonso,[...]. Breast Cancer Res Treat 2005
122
30

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
30

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells.
P Tassone, P Tagliaferri, A Perricelli, S Blotta, B Quaresima, M L Martelli, A Goel, V Barbieri, F Costanzo, C R Boland,[...]. Br J Cancer 2003
254
20

Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy.
Tomasz Byrski, Jacek Gronwald, Tomasz Huzarski, Ewa Grzybowska, Magdalena Budryk, Malgorzata Stawicka, Tomasz Mierzwa, Marek Szwiec, Rafal Wisniowski, Monika Siolek,[...]. J Clin Oncol 2010
372
20

Optimal selection of individuals for BRCA mutation testing: a comparison of available methods.
Paul A James, Rebecca Doherty, Marion Harris, Bickol N Mukesh, Alvin Milner, Mary-Anne Young, Clare Scott. J Clin Oncol 2006
88
20

Histopathology of BRCA1- and BRCA2-associated breast cancer.
Emiliano Honrado, Javier Benítez, José Palacios. Crit Rev Oncol Hematol 2006
57
20

Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction.
Yu Chuan Tai, Sining Chen, Giovanni Parmigiani, Alison P Klein. Breast Cancer Res 2008
18
20

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
20

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
20

Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients.
T Byrski, T Huzarski, R Dent, J Gronwald, D Zuziak, C Cybulski, J Kladny, B Gorski, J Lubinski, S A Narod. Breast Cancer Res Treat 2009
221
20

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.
Annegien Broeks, Marjanka K Schmidt, Mark E Sherman, Fergus J Couch, John L Hopper, Gillian S Dite, Carmel Apicella, Letitia D Smith, Fleur Hammet, Melissa C Southey,[...]. Hum Mol Genet 2011
132
20

Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers.
Nadine Tung, Alexander Miron, Stuart J Schnitt, Shiva Gautam, Katharina Fetten, Jennifer Kaplan, Yosuf Yassin, Ayodele Buraimoh, Ji-Young Kim, Attila M Szász,[...]. Breast Cancer Res 2010
27
20


An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA).
Georgia Chenevix-Trench, Roger L Milne, Antonis C Antoniou, Fergus J Couch, Douglas F Easton, David E Goldgar. Breast Cancer Res 2007
111
20

Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
J E Armes, L Trute, D White, M C Southey, F Hammet, A Tesoriero, A M Hutchins, G S Dite, M R McCredie, G G Giles,[...]. Cancer Res 1999
184
20


Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
20

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.
William D Foulkes, Ingunn M Stefansson, Pierre O Chappuis, Louis R Bégin, John R Goffin, Nora Wong, Michel Trudel, Lars A Akslen. J Natl Cancer Inst 2003
696
20

The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.
S R Lakhani, B A Gusterson, J Jacquemier, J P Sloane, T J Anderson, M J van de Vijver, D Venter, A Freeman, A Antoniou, L McGuffog,[...]. Clin Cancer Res 2000
163
20

Tissue-based predictors of germ-line BRCA1 mutations: implications for triaging of genetic testing.
Jeannine de la Cruz, Fabrice Andre, Robyn K Harrell, Roland L Bassett, Banu Arun, Marie-Christine Mathieu, Suzette Delaloge, Michael Z Gilcrease. Hum Pathol 2012
3
66

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.
José Palacios, Emiliano Honrado, Ana Osorio, Alicia Cazorla, David Sarrió, Alicia Barroso, Sandra Rodríguez, Juan C Cigudosa, Orland Diez, Carmen Alonso,[...]. Clin Cancer Res 2003
133
20

Linkage of early-onset familial breast cancer to chromosome 17q21.
J M Hall, M K Lee, B Newman, J E Morrow, L A Anderson, B Huey, M C King. Science 1990
20

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
20

Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
Yutaka Kondo, Lanlan Shen, Alfred S Cheng, Saira Ahmed, Yanis Boumber, Chantale Charo, Tadanori Yamochi, Takeshi Urano, Koichi Furukawa, Bernard Kwabi-Addo,[...]. Nat Genet 2008
470
10

Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer.
Ee Ming Wong, Melissa C Southey, Stephen B Fox, Melissa A Brown, James G Dowty, Mark A Jenkins, Graham G Giles, John L Hopper, Alexander Dobrovic. Cancer Prev Res (Phila) 2011
112
10

Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, Maggie C U Cheang, Samuel Leung, David Voduc, Tammi Vickery, Sherri Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu,[...]. J Clin Oncol 2009
10

DNA methylation and gene expression differences in children conceived in vitro or in vivo.
Sunita Katari, Nahid Turan, Marina Bibikova, Oluwatoyin Erinle, Raffi Chalian, Michael Foster, John P Gaughan, Christos Coutifaris, Carmen Sapienza. Hum Mol Genet 2009
278
10

Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Mark Clendenning, Kaisa Sotamaa, Thomas Prior, Judith A Westman,[...]. J Clin Oncol 2008
547
10

The search for unaffected individuals with Lynch syndrome: do the ends justify the means?
Heather Hampel, Albert de la Chapelle. Cancer Prev Res (Phila) 2011
96
10

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Peter C Fong, David S Boss, Timothy A Yap, Andrew Tutt, Peijun Wu, Marja Mergui-Roelvink, Peter Mortimer, Helen Swaisland, Alan Lau, Mark J O'Connor,[...]. N Engl J Med 2009
10

Loss of IGF2 imprinting: a potential marker of colorectal cancer risk.
Hengmi Cui, Marcia Cruz-Correa, Francis M Giardiello, David F Hutcheon, David R Kafonek, Sheri Brandenburg, Yiqian Wu, Xiaobing He, Neil R Powe, Andrew P Feinberg. Science 2003
546
10

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.
Marjolijn J L Ligtenberg, Roland P Kuiper, Tsun Leung Chan, Monique Goossens, Konnie M Hebeda, Marsha Voorendt, Tracy Y H Lee, Danielle Bodmer, Eveline Hoenselaar, Sandra J B Hendriks-Cornelissen,[...]. Nat Genet 2009
481
10

Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa.
Kristin Wallace, Maria V Grau, A Joan Levine, Lanlan Shen, Randala Hamdan, Xinli Chen, Jiang Gui, Robert W Haile, Elizabeth L Barry, Dennis Ahnen,[...]. Cancer Prev Res (Phila) 2010
81
10

Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon.
J P Issa, Y L Ottaviano, P Celano, S R Hamilton, N E Davidson, S B Baylin. Nat Genet 1994
954
10

Cancer prevention: epigenetics steps up to the plate.
Jean-Pierre Issa. Cancer Prev Res (Phila) 2008
41
10


Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers.
Minjie Wei, Jinhua Xu, James Dignam, Rita Nanda, Lise Sveen, James Fackenthal, Tatyana A Grushko, Olufunmilayo I Olopade. Breast Cancer Res Treat 2008
68
10



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.